-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Radiopharm Theranostics To Meet With U.S. FDA To Align On Pivotal Phase 3 Trial Design For Rad 101 In Diagnosis Of Brain Metastases

Reuters·08/17/2026 12:37:37

Please log in to view news